bioRxivBioengineeringPreprint
Stage-specific CAR-mediated signaling generates naive-like, TCR-null CAR T cells from induced pluripotent stem cells
Sang Pil YooiD, Xuegang YuaniD, Claire EngstromiD, Patrick C. ChangiD, Suwen LiiD, Lindsay E. LathropiD, J. LaGosh, Satvik Saripalli, Anthony AzzuniD, Vincenzo CalvaneseiD, Hanna K. A. MikkolaiD, Christopher SeetiD, Donald B. KohniD, Gay M. CrooksiD
Abstract
Genetically modified, induced pluripotent stem cells (iPSCs) offer a promising allogeneic source for the generation of functionally enhanced, chimeric antigen receptor (CAR) T cells. However, the signaling of CARs during early T cell development and the removal of the endogenous T cell receptor required to prevent alloreactivity pose significant challenges to the production of mature conventional CAR T cells from iPSCs. Here, we show that TCR-null, CD8{beta} CAR T cells can be efficiently generated from iPSCs by engineering stage-specific onset of CAR expression and signaling to both permit conventional T cell development and to induce efficient positive selection. CAR T cells produced using this approach displayed a uniform, naive T cell phenotype and demonstrated superior antigen-specific cytotoxicity compared to iPSC-derived effector memory CAR T cells. Multimodal sequencing revealed CAR-mediated positive selection induced the persistent upregulation of key transcription factors involved in naive T cell development. Achieving precise control of CAR expression and signaling in developmentally sensitive T precursors will be critical to realizing the full potential for "off-the-shelf", iPSC-derived cellular therapies.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Generation of effector CD4+ T cells from Human iPSC
Julian Amirault, Dar M. Heinze, … Gustavo Mostoslavsky·Stem Cell ReportsPeer-reviewed·Aug 27, 2026
- Generation of iPSC-derived CD4+ Th1 cells enhancing chimeric antigen receptor-T cell cytotoxicity
Yoshiki Furukawa, Midori Ishii, … Miki Ando·bioRxiv·Apr 24, 2025
- A Serum- and Feeder-Free System to Generate CD4 and Regulatory T Cells from Human iPSCs
- Efficient Generation of Functional TCRαβ+ Cytotoxic T Cells from hiPSCs via Small-Molecule Modulation
Caroline Kubaczka, Netra K. Kambli, … Thorsten M. Schlaeger·bioRxiv·Apr 1, 2026
- Generation of CD34+CD43+ hematopoietic progenitors to induce thymocytes from human pluripotent stem cells
Léa Flippe, Anne Gaignerie, … Carole Guillonneau·CellsPeer-reviewed·Dec 14, 2022
- Tunable differentiation of human CD4+ and CD8+ T cells from pluripotent stem cells
Ross D. Jones, Kevin Salim, … Peter W. Zandstra·Cell stem cellPeer-reviewed·Jan 1, 2026